VEGF isoform

Details for Australian Patent Application No. 2002317333 (hide)

Owner University of Bristol

Inventors Bates, David; Harper, Steven

Agent Watermark

Pub. Number AU-B-2002317333

PCT Number PCT/GB02/03213

PCT Pub. Number WO2003/012105

Priority 0118836.6 01.08.01 GB; 0202817.3 06.02.02 GB

Filing date 12 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 12 July 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 0118836.6 01.08.01 GB; 0202817.3 06.02.02 GB

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002317333

12 July 2007 Application Accepted

  Published as AU-B-2002317333

8 November 2007 Standard Patent Sealed

22 January 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 18 Nov 2008. Address for service in Australia - Watermark Patent & Trademark Attorneys 302 Burwood Road Hawthorn VIC 3122

25 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Nov 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002317334-ANALYTICAL TECHNIQUE

2002317332-ANTI-NEOPLASTIC VIRAL AGENTS